Urine drugs of abuse testing at the point-of-care: Clinical interpretation and programmatic considerations with specific reference to the Syva Rapid Test (SRT)

Clinica Chimica Acta

Volumn 307, Issue 1-2, 2001, Pages 27-32

  Yang, Jane M ^a   Lewandrowski, Kent B ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Drugs of abuse screening; Point of care

Indexed keywords

ALCOHOL; PARACETAMOL; SALICYLIC ACID; TRICYCLIC ANTIDEPRESSANT AGENT;

CONFERENCE PAPER; CROSS REACTION; DEVICE; DRUG ABUSE; DRUG SCREENING; HUMAN; HUMAN CELL; HUMAN TISSUE; LABORATORY DIAGNOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; SCREENING TEST; URINALYSIS;

CROSS REACTIONS; HUMANS; POINT-OF-CARE SYSTEMS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STREET DRUGS; SUBSTANCE ABUSE DETECTION;

EID: 0035037398     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-8981(01)00457-0     Document Type: Conference Paper

References (2)

1. Harvey M. Point of care laboratory testing in critical care. Am. J. Crit. Care. 8:1999;72-83.
2. Cone E.J., Dickerson S., Paul B.D., Mitchell J.M. Forensic drug testing for opiates: IV. Analytical sensitivity, specificity and accuracy of commercial urine opiate immunoassays. J. Anal. Toxicol. 16:1992;72-78.